Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-26T17:13:12.025Z Has data issue: false hasContentIssue false
  • English
  • Français

Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk

Published online by Cambridge University Press:  16 April 2020

Enzo Emanuele ,
Maria V. Carlin ,
Angela D’Angelo ,
Emmanouil Peros ,
Francesco Barale ,
Diego Geroldi  and
Pierluigi Politi
Enzo Emanuele*
Affiliation:
Molecular Medicine Laboratory, Clinica Medica 2, IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi, 2, 27100 Pavia, Italy
Maria V. Carlin
Affiliation:
Servizio Psichiatrico di Diagnosi e Cura, IRCCS Policlinico San Matteo, ASL, University of Pavia, Pavia, Italy
Angela D’Angelo
Affiliation:
Molecular Medicine Laboratory, Clinica Medica 2, IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi, 2, 27100 Pavia, Italy
Emmanouil Peros
Affiliation:
Molecular Medicine Laboratory, Clinica Medica 2, IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi, 2, 27100 Pavia, Italy
Francesco Barale
Affiliation:
Servizio Psichiatrico di Diagnosi e Cura, IRCCS Policlinico San Matteo, ASL, University of Pavia, Pavia, Italy
Diego Geroldi
Affiliation:
Molecular Medicine Laboratory, Clinica Medica 2, IRCCS Policlinico San Matteo, University of Pavia, Piazzale Golgi, 2, 27100 Pavia, Italy
Pierluigi Politi
Affiliation:
Servizio Psichiatrico di Diagnosi e Cura, IRCCS Policlinico San Matteo, ASL, University of Pavia, Pavia, Italy
*
*Corresponding author. Tel.: +39 0382 50 2092; fax: +39 0382 52 6259. E-mail address:lab.genmolcl@smatteo.pv.it (E. Emanuele).
Get access

Abstract

An increased incidence of adverse cardiovascular events has been reported in psychiatric patients, but the exact mechanisms underlying this association are still uncertain. Elevated plasma level of lipoprotein(a) [Lp(a)] is an independent risk factor for atherothrombotic disease in the general population. To study the implications of Lp(a) in psychiatric patients, we measured the plasma levels of Lp(a) in 74 patients with psychiatric disorders (39 schizophrenia, 10 major depression, 13 bipolar disorder and 12 personality disorder) and 74 healthy controls. The Lp(a) levels of the patient groups with schizophrenia, major depression and bipolar disorder were significantly higher than that of the control group. The median Lp(a) value of these diagnostic groups was comparable with those reported in patients with prior atherothrombotic events. On the other hand, no differences were found among personality disorder and controls. Our findings suggest that the elevation of plasma Lp(a) may contribute to increased cardiovascular risk in several patients with psychiatric disorders.

Keywords

Major depressionSchizophreniaBipolar disorderLipoprotein(a)Cardiovascular risk
Type
Original article
Information
European Psychiatry , Volume 21 , Issue 2 , March 2006 , pp. 129 - 133
Copyright
Copyright © Elsevier SAS 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Albers, J.J.Marcovina, S.M.Lodge, M.S.The unique lipoprotein(a): properties and immunochemical measurement. Clin. Chem. 1990;36:2019–2026.CrossRefGoogle ScholarPubMed
Anda, R.Williamson, D.Jones, D.Macera, C.Eaker, E.Glassman, A.et al.Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993;4:285–294.CrossRefGoogle Scholar
Bihari-Varga, M.Gruber, E.Rotheneder, M.Zechner, R.Kostner, G.M.Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Arteriosclerosis 1988;8:851–857.CrossRefGoogle ScholarPubMed
Cassidy, F.Carroll, B.J.Vascular risk factors in late onset mania. Psychol. Med. 2002;32:359–362.CrossRefGoogle ScholarPubMed
Cremer, P.Nagel, D.Labrot, B.Mann, H.Muche, R.Elster, H.et al.Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Gottingen Risk, Incidence and Prevalence Study (GRIPS). Eur. J. Clin. Invest. 1994;24:444–453.CrossRefGoogle Scholar
Hopkins, P.N.Wu, L.L.Hunt, S.C.James, B.C.Vincent, G.M.Williams, R.R.Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 1997;17:2783–2792.CrossRefGoogle ScholarPubMed
Horrobin, D.F.Bennett, C.N.Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukotrienses Essent Fatty Acids 1999;60:217–234.CrossRefGoogle ScholarPubMed
Imhof, A.Rothenbacher, D.Khuseyinova, N.Hoffmeister, A.Maerz, W.Nauck, M.et al.Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease. J. Cardiovasc. Risk 2003;10:362–370.CrossRefGoogle Scholar
Joynt, K.E.Whellan, D.J.O’Connor, C.M.Depression and cardiovascular disease: mechanisms of interaction. Biol. Psychiatry 2003;54:248–261.CrossRefGoogle ScholarPubMed
Kojima, S.Harpel, P.C.Rifkin, D.B.Lipoprotein(a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration. J. Cell Biol. 1991;113:1439–1445.CrossRefGoogle ScholarPubMed
Kostner, G.M.Avogaro, P.Cazzolato, G.Marth, E.Bittolo-Bon, G.Quinci, G.B.Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 1987;38:51–61.CrossRefGoogle Scholar
Lippi, G.Guidi, G.Lipoprotein(a): an emerging cardiovascular risk factor. Crit. Rev. Clin. Lab. Sci. 2003;40:1–42.CrossRefGoogle ScholarPubMed
Maes, M.Evidence for an immune response in major depression: a review and hypothesis. Prog. Neuropsychopharmacol. Biol. Psychiatry 1995;19:11–38.CrossRefGoogle ScholarPubMed
Maes, M.Bosmans, E.Suy, E.Vandervorst, C.DeJonckheere, C.Raus, J.Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1b and soluble interleukin-2 receptor production. Acta Psychiatr. Scand. 1991;84:379–386.CrossRefGoogle Scholar
Maes, M.Van der Planken, M.Van Gastel, A.Desnyder, R.Blood coagulation and platelet aggregation in major depression. J. Affect. Disord. 1996;40:35–40.CrossRefGoogle ScholarPubMed
McCreadie, R.G.Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br. J. Psychiatry 2003;183:534–539.Google ScholarPubMed
McKenney, J.Niacin for dyslipidemia: considerations in product selection. Am. J. Health Syst. Pharm. 2003;60:995–1005.CrossRefGoogle ScholarPubMed
Messamore, E.Hoffman, W.F.Janowsky, A.The niacin skin flush abnormality in schizophrenia: a quantitative dose-response study. Schizophr. Res. 2003;62:251–258.CrossRefGoogle ScholarPubMed
Milionis, H.J.Mittari, V.Exarchakos, G.Kalaitzidis, R.Skevas, A.T.Elisaf, M.S.Lipoprotein(a) and acute-phase response in patients with vestibular neuronitis. Eur. J. Clin. Invest. 2003;33:1045–1050.CrossRefGoogle ScholarPubMed
Milionis, H.J.Efstathiadou, Z.Tselepis, A.D.Bairaktari, E.T.Tsironis, L.D.Tsatsoulis, A.et al.Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine. Thyroid 2003;13:365–369.CrossRefGoogle ScholarPubMed
Miwa, K.Nakagawa, K.Yoshida, N.Taguchi, Y.Inoue, H.Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm. J. Am. Coll. Cardiol. 2000;35:1200–1205.CrossRefGoogle ScholarPubMed
Musselman, D.L.Evans, D.L.Nemeroff, C.B.The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch. Gen. Psychiatry 1998;55:580–592.CrossRefGoogle Scholar
O’connor, C.M.Gurbel, P.A.Serebruany, V.L.Depression and ischemic heart disease. Am. Heart J. 2000;140:63–69.CrossRefGoogle ScholarPubMed
Palabrica, T.M.Liu, A.C.Aronovitz, M.J.Furie, B.Lawn, R.M.Furie, B.C.Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med 1995;256–259.CrossRefGoogle ScholarPubMed
Plotsky, P.M.Owens, M.J.Nemeroff, C.B.Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 1998;21:293–307.CrossRefGoogle ScholarPubMed
Politi, P.Piccinelli, M.Klersy, C.Madini, S.Segagni, L.G.Fratti, C.et al.Mortality in psychiatric patients 5–21 years after hospital admission in Italy. Psychol. Med. 2002;32:227–237.CrossRefGoogle Scholar
Ramharack, R.Spahr, M.A.Kreick, J.S.Sekerke, C.S.Expression of apolipoprotein[a] and plasminogen mRNAs in cynomolgus monkey liver and extrahepatic tissues. J. Lipid Res. 1996;37:2029–2040.Google ScholarPubMed
Rhoads, G.G.Dahlen, G.Berg, K.Morton, N.E.Dannenberg, A.L.Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540–2544.CrossRefGoogle ScholarPubMed
Rouy, D.Grailhe, P.Nigon, F.Chapman, J.Angles-Cano, E.Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator: in vitro studies in a plasma milieu. Arterioscler. Thromb. 1991;11:629–638.CrossRefGoogle Scholar
Scanu, A.M.Hinman, J.Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels. Lipids 2002;37:439–444.CrossRefGoogle ScholarPubMed
Schaefer, E.J.Lamon-Fava, S.Jenner, J.L.McNamara, J.R.Ordovas, J.M.Davis, C.E.et al.Lipoprotein(a) levels and risk of coronary heart disease in men: the Lipid Research Clinics Coronary Primary Prevention Trial. JAMA 1994;271:999–1003.CrossRefGoogle ScholarPubMed
Tavares, H.Yacubian, J.Talib, L.L.Barbosa, N.R.Gattaz, W.F.Increased phospholipase A2 activity in schizophrenia with absent response to niacin. Schizophr. Res. 2003;61:1–6.CrossRefGoogle ScholarPubMed
Terres, W.Tatsis, E.Pfalzer, B.Beil, F.U.Beisiegel, U.Hamm, C.W.Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 1995;91:948–950.CrossRefGoogle Scholar
Utermann, G.Kraft, H.G.Menzel, H.J.Hopferwieser, T.Seitz, C.Genetics of the quantitative Lp(a) lipoprotein trait. I. Relation of LP(a) glycoprotein phenotypes to Lp(a) lipoprotein concentrations in plasma. Hum. Genet. 1988;78:41–46.CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.